Filing Details

Accession Number:
0001127602-20-013886
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-16 16:57:03
Reporting Period:
2020-04-15
Accepted Time:
2020-04-16 16:57:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643746 H. Lorence Kim C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-04-15 6,177 $34.24 1,236,333 No 4 S Direct
Common Stock Disposition 2020-04-15 1,517 $35.81 1,234,816 No 4 S Direct
Common Stock Disposition 2020-04-15 4,566 $36.57 1,230,250 No 4 S Direct
Common Stock Disposition 2020-04-15 7,340 $37.62 1,222,910 No 4 S Direct
Common Stock Disposition 2020-04-15 400 $38.24 1,222,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.74 to $34.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.08 to $36.08 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.14 to $37.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.16 to $38.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.17 to $38.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.